Profil wykonawcy
AMGEN BIOFARMACEUTICA, LDA
PT- Zamówienia
- 17
- Łączna wartość zamówień
- 354 843 544 €
- Kraje
- countries.PT
- Ostatnie zamówienie
- 12 maj 2026
- Wygasają w ciągu 12 miesięcy
- 0
Historia zamówień
| Data | Zamawiający | Tytuł | Kategoria | Wartość | Kraj | Wygasa | Źródło |
|---|---|---|---|---|---|---|---|
| 12.05.2026 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 261G000462 - Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta | — | 396,6 tys. € | PT | — | Zobacz w TED ↗ |
| 19.03.2026 | Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | Portugal – Various medicinal products – IMUNOMODULADORES | — | 633,2 tys. € | PT | — | Zobacz w TED ↗ |
| 21.10.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] | — | 416,3 tys. € | PT | — | Zobacz w TED ↗ |
| 12.08.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the musculo-skeletal system – 2024/0780 - DENOSUMAB [120 MG; SOL INJ; FRS] | — | 262,0 tys. € | PT | — | Zobacz w TED ↗ |
| 12.08.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Medicinal products for the musculo-skeletal system – 2024/0780 - DENOSUMAB [120 MG; SOL INJ; FRS] | — | 52,4 tys. € | PT | — | Zobacz w TED ↗ |
| 15.07.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/0304 - ROMIPLOSTIM [250 µG; PÓ SOL INJ; F/AMP] | — | 68,9 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - ENZALUTAMIDA [40 MG; CÁP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS] | — | 89,6 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491-CARFILZOMIB [60 MG; PÓ SOL INJ; FRS] (C23135) | — | 750,0 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491-CARFILZOMIB [60 MG; PÓ SOL INJ; FRS] (C23135) | — | 745,5 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - ENZALUTAMIDA [40 MG; CÁP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS] | — | 931,8 tys. € | PT | — | Zobacz w TED ↗ |
| 17.06.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - ENZALUTAMIDA [40 MG; CÁP/ COMP]ECULIZUMAB [300 MG; SOL INJ; FRS] | — | 188,2 tys. € | PT | — | Zobacz w TED ↗ |
| 02.04.2025 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Pharmaceutical products – 251G000717 - ADALIMUMAB 40 MG/0,4 ML SOL INJ BIOSSIMILAR CANETA ( AMGEVITA ) | — | 292,3 tys. € | PT | — | Zobacz w TED ↗ |
| 03.12.2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Blood products – 2023/304 - Medicamentos do grupo 4: sangue | — | 308,5 tys. € | PT | — | Zobacz w TED ↗ |
| 23.10.2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (B707) | — | 42,2 tys. € | PT | — | Zobacz w TED ↗ |
| 22.10.2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (P749) | — | 37,7 tys. € | PT | — | Zobacz w TED ↗ |
| 22.10.2024 | Unidade Local de Saúde Santa Maria, E.P.E. | Portugal – Antineoplastic and immunomodulating agents – 2023/491-Medicamentos do foro oncológico e imunomoduladores (P749) | — | 188,3 tys. € | PT | — | Zobacz w TED ↗ |
| 16.04.2024 | Serviço de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM, EPERAM) | Portugal – Various medicinal products – ECULIZUMAB | — | 349,4 mln € | PT | — | Zobacz w TED ↗ |